S&P 500 Industrials Sector SEC Filings — March 18, 2026

18-03-2026

On March 18, 2026, Great Southern Bancorp, Inc., the holding company for Great Southern Bank, declared a $0.43 per common share dividend for the first quarter of the calendar year ending December 31, 2026. The announcement was detailed in a press release attached as Exhibit 99.1 to the Form 8-K filing.

18-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 18, 2026, announcing the issuance of a press release titled 'AITX's RAD Unveils Rebuilt radsecurity.com'. The press release is attached as Exhibit 99.1 under Item 9.01. The filing is furnished under Item 8.01 and not deemed filed for liability purposes.

18-03-2026

18-03-2026

Heritage Commerce Corp (HTBK) filed a supplement to the joint proxy statement/prospectus for its merger with CVB Financial Corp (CVBF), announced December 17, 2025, with shareholder meetings scheduled for March 26, 2026, to address disclosure claims from three lawsuits and demand letters alleging deficiencies. While CVBF and HTBK deny merit in the claims and believe no supplements were required, they provided additional disclosures on share counts, director ownership, executive employment outcomes, and updated peer group financial tables to moot claims and avoid litigation delays. The merger remains on track, but the litigation introduces risks of potential delays or adverse effects.

• ·Lawsuits: Thompson v. Heritage Commerce Corp et al. (NY Supreme Court, Case No. 651158/2026, filed Feb 25, 2026); Johnson v. Heritage Commerce Corp et al. (NY Supreme Court, Case No. 651177/2026, filed Feb 26, 2026); Siegel v. Abate et al. (CA Superior Court Santa Clara, Case No. 26CV488158, filed Mar 3, 2026).
• ·CVBF S-4 registration effective Feb 12, 2026; joint proxy mailed Feb 13, 2026.
• ·Citizens and Heritage Bank notified executives Edmonds-Waters, Fonti, Sa, Just, Sabnani of position eliminations post-merger with change-in-control severance.
• ·Former director retired Dec 31, 2025, impacting director share count.

18-03-2026

Laser Photonics Corp filed an 8-K on March 18, 2026 (AccNo: 0001493152-26-010669, Size: 658 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction values, financial metrics, period-over-period comparisons, or quantitative impacts are disclosed. This is a multi-item filing with no details on positive or negative effects provided.

18-03-2026

Tonix Pharmaceuticals Holding Corp. dismissed EisnerAmper LLP as its independent registered public accounting firm on March 16, 2026, and simultaneously appointed PricewaterhouseCoopers LLP (PwC) as its new auditor for the year ending December 31, 2026. The change was approved by the Audit Committee and not due to any disagreements on accounting principles, auditing scope, or procedures. Prior audit reports for fiscal years 2024 and 2025 included a going concern explanatory paragraph due to continuing losses and negative cash flows, while previously disclosed material weaknesses in internal controls were remediated by December 31, 2024, without financial restatements.

18-03-2026

Tecogen Inc. reported FY2025 revenues of $27.07M, up 19.7% YoY from $22.62M, driven by Products segment growth of 105.5% to $9.13M and Services up 3.4% to $16.62M; however, Q4 revenues fell 12.5% to $5.32M with Products down 68.1% to $0.46M and Energy Production down 28.3%, while net loss widened to $8.25M from $4.76M due to $1.11M goodwill impairment, higher operating expenses up 25.4%, and gross margins declining to 36.3% from 43.6%. CEO highlighted upcoming positive updates on Vertiv chiller pipeline, data center opportunities, and a pilot project, amid investments in manufacturing expansion and R&D. Cash balance rose to $12.43M, supported by $17.4M from financing, despite $9.91M cash burn from operations.

• ·EPS FY2025 loss of $0.30/share vs $0.19/share in FY2024; Q4 2025 loss of $0.13/share vs $0.05/share.
• ·Adjusted EBITDA FY2025 negative $5.64M vs negative $3.63M in FY2024; Q4 2025 negative $2.43M vs negative $0.69M.
• ·Total assets $36.99M as of Dec 31, 2025 vs $31.09M Dec 31, 2024.
• ·Conference call scheduled for March 18, 2026 at 9:30am ET.

18-03-2026

Janus Henderson filed this DEFA14A on March 18, 2026, providing additional disclosures on participants in the proxy solicitation for a proposed transaction, including directors, executive officers, and employees. It references the definitive proxy statement filed March 11, 2026 (mailed March 12), Funds' proxies filed March 2, 2026, and Schedule 13E-3 filed March 11, 2026. Investors are urged to review these and related SEC filings for full details on the transaction.

• ·Janus Henderson Annual Meeting Proxy Statement filed March 21, 2025
• ·Funds' proxy statements filed March 2, 2026
• ·Documents available at https://www.sec.gov or https://ir.janushenderson.com

18-03-2026

18-03-2026

Genprex announced its research collaborators will present three posters at the 2026 AACR Annual Meeting (April 17-22) featuring positive preclinical data on Reqorsa Gene Therapy (quaratusugene ozeplasmid, Quar Oze) in lung cancer models, including 79% tumor shrinkage in ALK+ NSCLC when combined with alectinib (vs. 60% for alectinib alone) and up to 67% complete tumor regression in Tusc2 KO mice. However, studies identified significant resistance with 50% of NSCLC cell lines and PDXOs showing primary resistance to TUSC2, and 20-30% of tumors resistant across models. Findings also highlight TROP2 low/PTEN high as potential resistance biomarkers and enhanced NK cell cytotoxicity.

• ·Poster 1: 'TROP2 and PTEN are biomarkers of primary resistance to TUSC2 gene therapy in non-small cell lung cancer'
• ·Poster 2: 'Quaratusugene ozeplasmid mediated TUSC2 upregulation in EML4-ALK bearing non-small cell lung carcinoma induces apoptosis and is highly effective in preclinical studies'
• ·Poster 3: 'Restoring TUSC2 function boosts NK cell cytotoxicity and antitumor immunity in vivo and in vitro'
• ·Quar Oze dose: 25 μg/mouse IV every three days; alectinib: 0.5 mg/kg (sensitive) or 15 mg/kg (resistant) oral daily
• ·Tumors started at ~100 mm³ for in vivo studies
• ·AACR location: San Diego, California

18-03-2026

Faraday Future Intelligent Electric Inc. announced an executive and employee share purchase initiative, where deferred compensation for March 1 to May 31, 2026, estimated at approximately $500,000 after-tax, will be used to repurchase Class A common stock, subject to board approval, securities laws, and trading policies. The repurchased shares will be transferred to participants to settle the deferred amounts, aiming to align interests with stockholders, support liquidity management, and counter potential illegal market manipulation and short selling. This follows the company's commitment to strategic execution amid capital markets volatility.

• ·Filing date: March 18, 2026; Event date: March 17, 2026
• ·Principal executive offices: 18455 S. Figueroa Street, Gardena, CA 90248
• ·Company preparing potential SEC submission regarding illegal market manipulation

18-03-2026

General Mills Inc (GIS) filed an 8-K on March 18, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), indicating an announcement of financial results. The filing includes interactive data and is sized at 1 MB, but no specific financial metrics, period-over-period comparisons, or performance details are provided in the excerpt. This appears consistent with prior quarterly earnings releases by the company.

• ·Filing Acc-no: 0001628280-26-019020
• ·CIK: 0000040704
• ·SIC: 2040 - GRAIN MILL PRODUCTS
• ·Fiscal Year End: 05/31

18-03-2026

Golden Growers Cooperative reported flat net income of $6.1M for 2025, up slightly 0.3% YoY from $6.0M, driven by modest 0.5% YoY corn revenue growth to $62.3M and 3.6% YoY increase in net income from ProGold LLC to $6.5M; however, corn expenses rose 0.4% YoY, other income declined 36.5% to $0.3M, G&A expenses increased 10.2%, and total assets fell to $20.3M from $24.9M amid higher member distributions of $10.7M (up 38% YoY). Income from operations grew 3.2% YoY to $5.8M, but members' equity decreased to $20.1M due to distributions exceeding net income. All directors are confirmed independent per defined criteria.

• ·Net cash used in operating activities remained flat at ($0.4M) for both 2025 and 2024.
• ·Cash and cash equivalents declined to $1.2M as of Dec 31 2025 from $1.3M.
• ·Short-term investments decreased to $4.6M from $7.3M; long-term investments fell to $0.05M from $0.4M.
• ·All directors are independent based on defined criteria, including thresholds like $120,000 compensation and $1M payment limits.
• ·EPS basic and fully diluted stable at $0.39 for both years.

18-03-2026

Spire Global reported Q4 2025 revenue of $15.8 million, down 27% YoY primarily due to the maritime business divestiture, though up 44% YoY and 36% QoQ excluding maritime. Net loss improved 49% YoY to $25.1 million with adjusted EBITDA of ($9.7) million (8% YoY improvement), while cash used in operations was $4.3 million, a 78% YoY improvement; full year 2025 revenue reached $71.6 million. FY2026 guidance projects $75-85 million revenue (41-61% YoY growth ex-maritime), but Q4 GAAP gross margin rose to 41% (+8pp YoY) amid ongoing losses.

• ·Debt-free balance sheet as of Dec 31, 2025
• ·Q4 revenue met mid-point of outlook; adjusted EBITDA better than high-end
• ·Q1 2026 revenue guidance $14.5-15.5M (incl. $1.7M maritime); FY2026 non-GAAP loss per share ($1.11)-($0.96)
• ·Selected by AiDASH for weather intelligence integration to enhance electric grid resilience

18-03-2026

Genasys Inc. held its 2026 Annual Meeting of Stockholders on March 17, 2026, electing all five director nominees to the Board for one-year terms, ratifying Baker Tilly US, LLP as independent auditor for the fiscal year ending September 30, 2026, and approving named executive officer compensation on an advisory basis. Shareholder participation was 25,083,917 shares out of 45,212,311 eligible (55.5% turnout). However, the executive compensation vote passed narrowly with 57.6% in favor versus 33.2% against, and director nominee Susan Lee Schmeiser received the highest withheld votes at 4,044,163 (24.7% of votes cast on her election).

• ·Director election votes - Richard S. Danforth: 13,145,959 For, 2,224,572 Withheld
• ·Director election votes - William H. Dodd: 13,965,420 For, 1,405,111 Withheld
• ·Director election votes - W. Craig Fugate: 13,879,560 For, 1,490,971 Withheld
• ·Director election votes - R. Rimmy Malhotra: 13,916,633 For, 1,453,898 Withheld
• ·Auditor ratification votes: 21,419,235 For, 2,005,498 Against, 1,659,184 Abstain
• ·Executive compensation advisory votes: 8,844,760 For, 5,107,733 Against, 1,418,038 Abstain
• ·Proxy statement filed with SEC on January 28, 2026

18-03-2026

Newbridge Acquisition Limited, a blank check company, announced on March 18, 2026, that commencing March 23, 2026, holders of its units (NBRGU) may elect to separately trade the underlying Class A ordinary shares (NBRG) and rights (NBRGR) on The Nasdaq Capital Market. Each unit consists of one Class A ordinary share and one right entitling the holder to one-eighth of one Class A ordinary share upon consummation of an initial business combination. Unseparated units will continue trading under NBRGU, and holders must contact transfer agent VStock Transfer LLC for separation.

• ·IPO registration statement (File No. 333-289966) effective September 30, 2025; post-effective amendment effective December 18, 2025.
• ·No fractional rights issued upon unit separation.
• ·Company incorporated in British Virgin Islands with principal offices in Wanchai, Hong Kong.

18-03-2026

On March 16, 2026, the Compensation Committee of Eagle Bancorp, Inc. approved 2026 Continuity Awards to senior executives Eric R. Newell, Evelyn K. Lee, and Ryan A. Riel (excluding CEO Susan Riel, who plans to retire) to ensure management stability during the CEO transition. The awards include cash payments totaling $1.175M ($425,000 each to Newell and Riel, $325,000 to Lee) payable March 27, 2026, subject to repayment if they leave early before June 30, 2027, and 4,086 RSUs each (valued at ~$100,000) vesting over three years. No financial performance metrics were reported.

• ·Cash awards subject to repayment if recipient voluntarily resigns (other than for good reason) or is terminated for cause prior to June 30, 2027.
• ·RSUs vest on the third anniversary of March 16, 2026, subject to the 2025 Equity Incentive Plan and RSU Award Agreement (Exhibit 10.1).
• ·Continuity Award Agreement form filed as Exhibit 10.2.

18-03-2026

Hilton Domestic Operating Company Inc., an indirect subsidiary of Hilton Worldwide Holdings Inc., entered into Amendment No. 12 to its Credit Agreement on March 18, 2026, extending the maturity of the senior secured Revolving Credit Facility to the earlier of five years from the amendment date or 91 days prior to existing term loan maturities. The amendment increases the letter of credit sublimit from $250M to $500M and the swingline borrowing sublimit from $100M to $200M, while setting SOFR-based interest margins starting at 1.00% subject to leverage-based step-ups. No declines or capacity reductions were reported.

• ·Interest margin for SOFR loans starts at 1.00% when first lien net leverage <=1.50x, with 0.25% step-ups for higher leverage tiers (<=2.50x, <=3.50x, >3.50x).
• ·Original Credit Agreement dated October 25, 2013; this is Amendment No. 12.

18-03-2026

Dr. Kaouthar Lbiati resigned as CEO of Hepion Pharmaceuticals, Inc. for personal reasons, effective immediately on March 16, 2026. The Board appointed Gary Stetz as interim CEO and director, Vincent LoPriore as Executive Chairman, Sireesh Appajosyula as director, and Chase LoPriore as director on the same date. There were no arrangements, understandings, or family relationships related to these changes.

• ·Filing date: March 18, 2026; earliest event date: March 16, 2026
• ·Trading symbol: HEPA on OTC QB
• ·No written communications under Rule 425, soliciting material under Rule 14a-12, or pre-commencement communications under Rule 14d-2(b) or 13e-4(c)
• ·Registrant not an emerging growth company

18-03-2026

United Bancorp's proxy statement seeks shareholder ratification of S.R. Snodgrass, P.C. as independent auditors for fiscal 2026, after they served in 2025 with audit fees rising 4.6% YoY to $181,251 from $173,242 in 2024, while no audit-related or tax fees were billed in either year. The filing also overviews executive compensation, including base salary, cash incentives tied to EPS and bank metrics, and equity under the 2018 Stock Incentive Plan with 311,790 awards granted as of December 31, 2025.

• ·S.R. Snodgrass, P.C. has served as independent auditors since 2022.
• ·No non-audit services provided under pre-approval exceptions in 2025.
• ·2018 Plan approved at 2018 Annual Meeting; 2008 Plan expired April 15, 2018.

18-03-2026

Christopher Giles resigned as Class II director of Jefferson Capital, Inc. effective March 18, 2026, to focus on other commitments, with no disagreements on company matters. The Board appointed Susan Atkins as Class II director (term until 2027 annual meeting) and James Pierce as Class III director (term until 2028 annual meeting). Each received stock options for 50,000 shares vesting equally over three years.

• ·Resignation not due to any disagreement with Company operations, policies, or practices.
• ·New director options: 50% exercise price at fair market value on grant date, 50% at fair market value plus $14.00.
• ·No arrangements/understandings for appointments; no family relationships with other directors/officers; no material interests under Item 404(a) of Regulation S-K.
• ·Company is an emerging growth company.

18-03-2026

IGC Pharma, Inc. filed a 10-KT Transition Report for the nine-month period from April 1, 2025, to December 31, 2025, following a Board-approved fiscal year-end change from March 31 to December 31 in December 2025; the company operates as a clinical-stage biotech with no pharmaceutical product revenue and expects ongoing operating losses. Lead candidate IGC-AD1 is in Phase 2 (CALMA trial) for agitation in Alzheimer’s dementia, with preclinical data suggesting broader potential, alongside early-stage TGR-63 and AI-enabled MINT-AD platform. Non-affiliate stock market value stood at approximately $18.5M as of June 30, 2025, with 98.8M common shares outstanding as of March 11, 2026.

• ·Corporate headquarters: 10224 Falls Road, Potomac, Maryland 20854
• ·Commission file number: 001-32830
• ·I.R.S. Employer Identification No.: 20-2760393
• ·Classified as non-accelerated filer and smaller reporting company

18-03-2026

Lattice Semiconductor Corp's DEF 14A proxy statement, filed March 18, 2026, includes the Audit Committee's approval of the FY ended January 3, 2026 financials from the 10-K filed February 13, 2026. GAAP gross margin improved 4.9% YoY to $356.9M (68.2%), and non-GAAP operating income grew 16.9% to $149.2M, with adjusted EBITDA up 13.0% to $183.0M. However, GAAP operating income declined 67.4% to $11.2M and net income fell 95.0% to $3.1M YoY.

• ·10-K for year ended Jan 3, 2026 filed with SEC on Feb 13, 2026.
• ·Stockholder proposals for inclusion in next proxy: no later than Nov 18, 2026.
• ·Other stockholder proposals/nominations: between Jan 1, 2027 (8am PT) and Jan 31, 2027 (5pm PT).
• ·Universal proxy notice deadline: March 2, 2027.

18-03-2026

Abacus Global Management, Inc. dismissed Grant Thornton LLP as its independent auditor and engaged KPMG LLP on March 16, 2026, with no disagreements, reportable events, or audit qualifications in prior reports for fiscal years 2024 and 2025. The Board appointed William McCauley as Chief Operating Officer on March 12, 2026, alongside salary increases for CEO Jay Jackson to $725,000 and McCauley to $500,000, plus performance-based RSUs and cash bonuses tied to 2026 Adjusted Net Income targets of $96M (target) and $192M (stretch). These incentives also include market cap triggers at $1.5B and one-time equity bonuses of up to 2M shares for Jackson and 1M for McCauley, pending shareholder approval of the 2026 LTIP.

• ·RSUs vest over three years post-determination date if performance targets met, with interpolation between 0-200% of target.
• ·One-time equity bonuses contingent on 2026 market cap or AUM targets.
• ·Auditor change effective immediately on March 16, 2026; GT letter dated March 18, 2026 filed as Exhibit 16.1.
• ·Company's common stock trades as ABX and 9.875% Fixed Rate Senior Notes due 2028 as ABXL on NYSE.

18-03-2026

Home Depot's FY2025 net sales rose 3.2% YoY to $164.7B from $159.5B, supported by a 1.4% increase in average ticket to $90.56 despite a 2.2% drop in customer transactions to 1,601.5 million. However, comparable sales grew only 0.3% (flat), operating income declined 2.9% to $20.9B, net earnings fell 4.3% to $14.2B, and diluted EPS decreased 4.6% to $14.23. ROIC also dropped sharply to 25.7% from 31.3%.

• ·Total stockholders’ equity increased to $12.8B from $6.6B YoY.
• ·Short-term debt rose sharply to $4.5B from $0.3B.
• ·Merchandise inventories grew to $25.8B from $23.5B.
• ·FY2024 included 53 weeks vs 52 weeks in FY2025.

18-03-2026

Great Lakes Dredge & Dock Corporation (GLDD) filed Amendment No. 2 to Schedule 14D-9 on March 18, 2026, disclosing early termination of the HSR Act waiting period on March 17, 2026, satisfying a key condition for the cash tender offer by Huron MergeCo., Inc. (subsidiary of Saltchuk Resources, Inc.) to acquire all outstanding shares at $17.00 per share pursuant to the February 10, 2026 Merger Agreement. Parent also commenced a separate tender offer and consent solicitation for GLDD's 5.25% Senior Notes due 2029 on March 18, 2026, which is not conditioned on the closing of the main Offer or Merger.

• ·HSR Notification and Report Forms filed by Parent and GLDD on March 3, 2026 with FTC and Antitrust Division.
• ·FTC granted early termination of HSR waiting period on March 17, 2026 at 3:28 p.m. Eastern Time.
• ·Indenture for Notes dated May 25, 2021, with Computershare Trust Company, N.A. as trustee.

18-03-2026

Phillips 66 Company, as borrower, and Phillips 66, as initial guarantor, entered into a $2.25 billion term loan credit agreement on March 18, 2026, with Mizuho Bank, Ltd. as administrative agent and various lenders including Bank of America, N.A., PNC Bank, N.A., The Toronto-Dominion Bank, New York Branch, Truist Bank, and MUFG Bank, Ltd. as co-syndication agents. The facility provides access to significant liquidity with standard terms including ABR and Term SOFR-based interest rates, but includes covenants on liens, indebtedness, and fundamental changes. No prior period comparisons or performance metrics are disclosed.

18-03-2026

Avidbank Holdings, Inc. filed its 10-K annual report on March 18, 2026, emphasizing a strategic focus on expanding its deposit base via commercial relationships, treasury management services, and specialized deposit products to enhance liquidity and non-interest income. The filing provides explanations of regulatory capital metrics like CET1 ratio and discloses extensive risk factors, including geographic concentration in the California Bay Area, volatile nonperforming assets, dependency on large depositors and borrowers, liquidity risks, and regulatory restrictions on dividends. In Q4 2025, 4,810 shares of common stock were surrendered by employees for tax withholding obligations related to restricted stock vesting at an average price of $25.12 per share, with none purchased under a public repurchase program and 282,433 shares remaining authorized.

• ·Share surrenders not part of publicly announced repurchase program.
• ·CET1 Risk-Based Capital Ratio excludes accumulated other comprehensive income per one-time election.

18-03-2026

Hills Bancorporation reported total assets of $4.57B as of December 31, 2025, up 4.5% YoY from $4.37B, with net loans growing 2.1% to $3.46B and net income surging 27.1% to $60.5M (EPS $6.81). Net interest income rose sharply 29.0% to $153.7M, driven by higher loan yields (5.66% vs 5.30%) and improved net interest margin (3.45% vs 2.78%), while interest expense declined 4.6% to $83.6M. However, time deposits fell 5.1% to $870.3M, interest-bearing demand deposits decreased 1.9% to $901.2M, and reliance on borrowings increased with other short-term borrowings at $297.7M (up from $332.8M prior but elevated vs 2023).

• ·Noninterest-bearing demand deposits increased 2.3% YoY to $577.6M.
• ·Savings deposits grew 11.2% YoY to $992.1M.
• ·Other short-term borrowings $297.7M (down 10.5% YoY from $332.8M but up significantly from 2023 $214.3M).
• ·FHLB borrowings $344.95M (up 80.3% YoY from $191.35M).
• ·Taxable securities up 9.3% YoY to $605.7M.
• ·Redeemable common stock held by ESOP $52.7M.

18-03-2026

On March 12, 2026, four independent directors of Graphjet Technology—Tan Song Jie, Chen Siow Woon, Ang Chee Yong, and Pwa Yee Guo—resigned from their positions on the board. The resignations were explicitly stated not to result from any disagreement with the company's management, operations, policies, or board on matters relating to business, strategy, or governance. The company, which was suspended from Nasdaq trading on November 13, 2025, filed this 8-K on March 18, 2026.

• ·Company incorporated in Cayman Islands with principal offices in Shah Alam, Selangor, Malaysia.
• ·Fiscal year end: September 30.
• ·Former name: Energem Corp (name change effective August 20, 2021).
• ·SEC file number: 001-41070; CIK: 0001879373.

18-03-2026

Lazard Global Total Return and Income Fund's proxy statement solicits votes for the Annual Meeting on April 30, 2026, to elect one Class I Director (Robert L. Forsyth) for a one-year term expiring in 2027 and three Class III Directors (Franci J. Blassberg, Richard Reiss, Jr., and Jennifer A. Ryan) for three-year terms expiring in 2029. As of the record date of March 11, 2026, 13,012,942 shares of common stock were outstanding, with all stockholders eligible to vote. The Board includes eight directors, comprising independent and interested directors affiliated with Lazard Asset Management LLC.

• ·Annual Meeting location: 30 Rockefeller Plaza, 58th Floor, Conference Room 58A, New York, NY 10112 at 3:00 p.m. Eastern Time
• ·Record date: March 11, 2026
• ·Fiscal year end: October 31
• ·Quorum requirement: Majority of votes entitled to be cast
• ·Fund is a closed-end investment company registered under the 1940 Act

18-03-2026

On March 12, 2026, Edible Garden AG Incorporated entered into exchange agreements with Streeterville Capital, LLC to exchange 121 shares of Series B Preferred Stock (stated value $121,000) for 50,840 shares of common stock. The exchange was conducted pursuant to the Section 3(a)(9) exemption under the Securities Act and was not registered. This transaction represents potential share dilution with no offsetting financial metrics disclosed.

• ·Exchange Shares determined by dividing Stated Value by Nasdaq Minimum Price on preceding trading day
• ·Securities registered: Common Stock (EDBL) and Warrants (EDBLW) on Nasdaq Stock Market LLC

18-03-2026

Vistagen Therapeutics, Inc. (VTGN) announced that Mary Rotunno resigned from its Board of Directors on March 17, 2026, effective April 1, 2026. The 8-K filing was signed by Shawn K. Singh, President and Chief Executive Officer. No reasons for the resignation or details on a replacement were disclosed.

• ·Company headquartered at 343 Allerton Ave., South San Francisco, California 94080
• ·Incorporated in Nevada; Commission File Number 000-54014; IRS EIN 20-5093315
• ·Common Stock trades under VTGN on Nasdaq Capital Market

18-03-2026

Lake Shore Bancorp, Inc. appointed Dennis Pollack to the Boards of Directors of the Company and Lake Shore Bank effective March 17, 2026, pursuant to a standstill agreement with The Stilwell Group, which remains in effect until the 2029 Annual Meeting of Stockholders. The Board views the addition as strengthening governance and expertise in key oversight areas, with no financial impacts or performance metrics disclosed. Stilwell congratulated the appointment, citing Pollack's extensive banking experience.

• ·Bank headquartered in Dunkirk, New York, with branches including four in Chautauqua County and six in Erie County.
• ·Agreement includes customary provisions regarding standstill, voting commitments, and other matters.

18-03-2026

Hewlett Packard Enterprise Company announced the launch and pricing of a $2B aggregate principal amount senior unsecured Notes offering on March 16, 2026, consisting of $300M Floating Rate Notes due 2028, $500M 4.500% Notes due 2028, $600M 4.600% Notes due 2029, and $600M 5.250% Notes due 2033. The Notes are expected to close on March 23, 2026, subject to customary conditions, and were underwritten by Barclays Capital Inc., BofA Securities, Inc., SG Americas Securities, LLC, and Wells Fargo Securities, LLC. The offering is registered under Form S-3 (No. 333-276221).

• ·Notes rank equally with all existing and future senior unsecured indebtedness
• ·Underwriting Agreement dated March 16, 2026, filed as Exhibit 1.1
• ·Registration statement on Form S-3 (No. 333-276221), effective December 22, 2023

18-03-2026

Graphene & Solar Technologies Ltd filed a 10-K/A amendment to its annual report on March 18, 2026, following a 10-K filed on February 25, 2026, and another amendment on February 2, 2026. The company's extensive filing history is marked by repeated notifications of inability to timely file (multiple NT 10-K and NT 10-Q forms), signaling ongoing compliance delays and no improvements in reporting timeliness. No financial metrics or operational data are detailed in the provided filing list.

• ·CIK: 0001497649
• ·SIC: 1000 - METAL MINING
• ·State of Incorporation: CO
• ·Fiscal Year End: September 30
• ·Business Address: 11201 NORTH TATUM BOULEVARD SUITE 300, PHOENIX, AZ 85028
• ·Phone: 602-388-8335
• ·CF Office: 01 Energy & Transportation

18-03-2026

Equity Bancshares, Inc. filed an 8-K/A on March 18, 2026, amending its January 2, 2026 Initial 8-K to include audited financial statements of acquired Frontier Holdings, LLC as of September 30, 2025 and 2024, and for the two years ended September 30, 2025, along with unaudited pro forma condensed consolidated combined financial information as of December 31, 2025 and for the year then ended. The merger with Frontier was completed effective January 1, 2026, pursuant to an agreement dated August 29, 2025. No specific financial metrics or performance changes are detailed in the filing text itself.

• ·Merger agreement dated August 29, 2025
• ·Initial 8-K filed January 2, 2026
• ·Exhibits include consent from Forvis Mazars, LLP (Exhibit 23.1)

18-03-2026

DuPont de Nemours, Inc. announced on March 18, 2026, plans to seek stockholder approval at its Annual Meeting for an amendment to its Certificate of Incorporation to enable a reverse stock split of its common stock at a ratio between 1-for-2 and 1-for-4, with the exact ratio to be determined by the Board of Directors. The Board has set March 30, 2026, as the record date for stockholders entitled to vote. Preliminary proxy materials will be filed with the SEC for review.

• ·Common stock: par value $0.01 per share, traded on New York Stock Exchange (DD)
• ·Solicitation material pursuant to Rule 14a-12 under the Exchange Act

18-03-2026

FingerMotion, Inc. (FNGR) announced a share exchange agreement to acquire Telforge, Inc., a U.S.-based voice and messaging telecom provider, by issuing up to 7,333,333 shares of common stock, comprising 2,333,333 closing shares and 5,000,000 milestone shares held in escrow contingent on achieving $2.5M and $5M in cumulative revenue plus secured contract value over 3-month and 6-month earnout periods post-closing. The deal aligns with FingerMotion's strategic expansion into telecom and infrastructure, expected to enable scaling of tens of millions of monthly minutes via Telforge's proprietary platform without added hardware costs and introduce a U.S. operating model. No financial performance declines or flat metrics are reported in this prospective announcement.

• ·Shares issued as restricted securities under Rule 144 exemption with registration rights provided.
• ·Additional transaction details to be filed in a forthcoming Form 8-K.
• ·FingerMotion vision to serve over 1 billion users in China and expand regionally.

18-03-2026

GD Culture Group Limited filed a definitive proxy statement on March 18, 2026, for its 2026 annual stockholder meeting on March 30, 2026, at 1:00 p.m. ET, to elect five directors (Proposal 1), ratify GGF CPA LTD as independent auditors for fiscal years ended December 31, 2025 and 2026 (Proposal 2), and approve potential adjournment to solicit more proxies (Proposal 3). As of the record date March 4, 2026, 60,759,711 shares of common stock were issued and outstanding, with a quorum requiring one-third of shares present in person or by proxy. The Board unanimously recommends voting FOR all proposals; no other matters are anticipated.

• ·Voting deadline for internet proxies: 12:59 p.m. ET on March 29, 2026
• ·Proposal 1 (Director Election) requires plurality of votes cast; broker non-votes have no impact
• ·Proposals 2 and 3 require majority of votes cast (excluding abstentions); Proposal 2 allows broker discretionary voting
• ·Annual report on Form 10-K for year ended December 31, 2024, accompanies notice (not part of proxy); 2025 10-K to be filed within 90 days after fiscal year-end

18-03-2026

Lottery.com Inc. filed an 8-K on 2026-03-18 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, obligation, equity sales, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no information on filing timeliness relative to the event.

18-03-2026

On March 18, 2026, the District Court for the District of New Jersey ordered a delay in the bench trial between Catalyst Pharmaceuticals, Inc. and Hetero USA, Inc., postponing it from March 23, 2026, to May 18, 2026. The trial pertains to the validity of the Company's Orange Book-listed patents for FIRDAPSE®, which are set to expire in 2032, 2034, and 2037. No financial impacts or outcomes from the trial were disclosed.

• ·Trial relates to patents listed in the FDA Orange Book

18-03-2026

Bank of Marin Bancorp (Nasdaq: BMRC), parent of Bank of Marin, announced that President and CEO Tim Myers and EVP and CFO David Bonaccorso will participate in the Raymond James Northern California Bank Investor Symposium on March 19, 2026. A copy of the investor presentation will be available on the company's website under Investor Relations on March 18, 2026, and is furnished as Exhibit 99.1.

• ·Presentation accessible at http://www.bankofmarin.com under “Investor Relations/News & Market Data/Presentations”

18-03-2026

StoneBridge Acquisition II Corp, a SPAC, reported total assets of $58.6M as of December 31, 2025, driven by $58M in trust account investments from its IPO (5,750,000 Class A shares at $10/share), a massive increase from $88k at December 31, 2024. Cash grew to $0.5M from $1.9k and shareholders' equity rose to $545k from $17k, while liabilities fell to $46k from $71k. However, the filing highlights risks including potential change in control from issuing substantial Class A shares, impacts on NOL carryforwards, and limitations on cash flow if debt is incurred, though current debt is minimal.

• ·Inception date: June 19, 2024
• ·IPO over-allotment option fully exercised on October 1, 2025
• ·Sponsor forfeited 825,000 Founder Shares on September 30, 2025; repurchased by Maxim and third-party investors at ~$0.013/share
• ·Schedule 13G filings: Glazer Capital (Feb 12, 2026), Mizuho (Feb 12, 2026), Wolverine (Feb 2, 2026)

18-03-2026

Independent Bank Corporation (NASDAQ: IBCP) announced a definitive merger agreement to acquire HCB Financial Corp. (OTCPK: HCBN) in a cash and stock transaction valued at approximately $70.2M, based on IBCP's closing stock price of $33.13 on March 17, 2026, resulting in a combined entity with $6.1B in total assets, $5.3B in deposits, and $4.7B in loans as of December 31, 2025. The deal is expected to be 6% accretive to IBCP's 2027 EPS with a projected CET1 ratio of 11.5% post-closing; however, it involves 4% tangible book value per share dilution, expected to earn back in 3.4 years. The transaction awaits regulatory and shareholder approvals and is targeted to close early in Q3 2026.

• ·IBCP to issue 1.590 shares of common stock plus $17.51 cash per outstanding HCB share.
• ·Conference call scheduled for March 19, 2026 at 9:00am ET with presentation slides.
• ·One HCB director to join IBCP and Independent Bank boards post-merger.

18-03-2026

Evolution Metals & Technologies Corp. (EM&T, NASDAQ: EMAT), formerly Welsbach Technology Metals Acquisition Corp., released a corporate video on March 18, 2026, showcasing its current commercial operations including production of sintered magnets, bonded magnets, and mid-stream critical minerals processing. The video is available on the company's investor relations website at https://evolution-metals.com/investor-relations/media. This information is furnished under Item 7.01 and not deemed filed.